Snowball logo
logo
8049

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

8049 โ€ข HK
HK$2.69+HK$0.04ย  (1.51%)
Estimate
Beta
0.292
Growth
Revenue, YoY
95.52%
Net income, YoY
135.21%
Dividends
Dividend yield
10.68%
Annual payout
HK$0.29
Next ex. div date
June 22, 27
Payout
59.63%
Div.growth, 5y
47.71%
Dividend growth streak
2 y
Div.rating
About the company
Ticker
8049
ISIN
CNE100000130
Country
Hong Kong
Sector (GICS)
Healthcare
Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People's Republic of China. The company provides Edaravone injection, compound brain comfort capsules, haikun kidney capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine zinc gluconate tablets, and Qianlie Guihuang Tablets. It also engages in the manufacture and distribution of beverages and prepackaged food, as well as health products. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.

Frequently asked questions

What sector does Jilin Province Huinan Changlong Bio-pharmacy Co Ltd (8049) operate in?

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Jilin Province Huinan Changlong Bio-pharmacy Co Ltd (8049) current stock price?

As of the latest data, Jilin Province Huinan Changlong Bio-pharmacy Co Ltd stock price is HK$2.69, with a previous close of HK$2.65. Jilin Province Huinan Changlong Bio-pharmacy Co Ltd gained HK$0.04 in the last trading session, representing a 1.51% increase.

What is Jilin Province Huinan Changlong Bio-pharmacy Co Ltd (8049) current market capitalization?

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd market cap is approximately 464.02 million.

What is Jilin Province Huinan Changlong Bio-pharmacy Co Ltd (8049) EBITDA?

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 136.89 million.

Does Jilin Province Huinan Changlong Bio-pharmacy Co Ltd (8049) pay dividends?

Yes. Jilin Province Huinan Changlong Bio-pharmacy Co Ltd pays annual dividends with an annualized yield of 10.68% and an estimated annual payout of HK$0.29 per share.

When is the next ex-dividend date for Jilin Province Huinan Changlong Bio-pharmacy Co Ltd (8049)?

The next ex-dividend date is scheduled for June 22, 2027.

What is Jilin Province Huinan Changlong Bio-pharmacy Co Ltd (8049) beta (volatility) score?

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd has a beta of 0.292, indicating lower volatility than the overall market.